Dr. Jean-Pierre Routy has dedicated the last three decades bringing science and treatment innovation to improve the life of persons with HIV and or cancer. He is an attending physician in the Division of Hematology and Director of Chronic Viral Illness Service at the McGill University health Centre in Montreal. He was promoted full Professor in 2012. His fight in AIDS related malignancies has led him to obtain the McGill University Louis Lowenstein Chair in Hematology & Oncology.
After completing his training in Medicine and Hematology-Oncology at University Aix-Marseille in 1986, he obtained a Postdoctoral Research Fellow Award from the Canadian HIV Trials Network (CTN).
As a Clinician-Scientist of Fonds de la recherche Québec en santé (FRQ-S), he was able to implement in 1996 the Montreal Primary HIV-Infection study, which generated important findings in HIV pathogenesis and drug resistance transmission.
His achievements have led Dr. Routy to become Director of the FRQ-S SIDA et maladies infectieuses and national co-director of the Immunotherapy and Vaccine Core at the Canadian Institutes of Health Research (CIHR) for HIV Trials Network. He is also a member of the HIV/AIDS Research Advisory Committee for the Federal Government of Canada.
Dr Routy has authored or co-authored over 360 peer-reviewed publications including articles in journals such as: New England Journal of Medicine, The Lancet, Nature, Nature Medicine, Blood, AIDS and Frontiers in immunology.
